FISHERMAN JASON S 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Nov 14, 2019
Insider Transaction Report
Form 4
FISHERMAN JASON S
Director
Transactions
- Exercise/Conversion
Common Stock
2019-11-14$3.28/sh+20,000$65,600→ 90,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-14−20,000→ 0 totalExercise: $3.28Exp: 2019-12-18→ Common Stock (20,000 underlying)
Holdings
- 1,500(indirect: By IRA)
Common Stock
Footnotes (1)
- [F1]This option was granted on December 18, 2009 and vested over a four year period with 25% of the shares vesting on the first anniversary of the grant date and an additional 6.25% vesting at the end of each three-month period thereafter.